Journal
ACS INFECTIOUS DISEASES
Volume 2, Issue 1, Pages 5-7Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.5b00146
Keywords
-
Categories
Funding
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986] Funding Source: NIH RePORTER
- Intramural NIH HHS [Z01 AI000986-01] Funding Source: Medline
Ask authors/readers for more resources
Influenza viruses are a significant public health threat, causing both annually circulating epidemics and unpredictable pandemics. Vaccination is the best means of control against individual cases of influenza and also for decreasing epidemic spread in the population. However, rapid influenza virus evolution requires continual reformulation of vaccines for annual influenza epidemics, and because pandemics cannot be accurately predicted, no current vaccine strategy can induce broad protection against all subtypes of influenza viruses. Recent work has suggested that such broadly protective, or universal, influenza virus vaccines might be achievable using vaccine strategies that target conserved B- and T-cell epitopes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available